Amarin Corporation PLC Selling, General and Administrative Expense of Revenue

Selling, General and Administrative Expense of Revenue of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative Expense of Revenue for the quarter ending June 30, 2022 was 92.82% (a -3.65% decrease compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative Expense of Revenue increased by 28.05%
  • Annual Selling, General and Administrative Expense of Revenue for 2021 was 70.03% (a -7.18% decrease from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2020 was 75.45% (a 0.2% increase from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2019 was 75.3% (a -23.96% decrease from previous year)
  • Twelve month Selling, General and Administrative Expense of Revenue ending June 30, 2022 was 78.6% (a 7.0% increase compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative Expense of Revenue increased by 10.05% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
78.6% 73.46% 69.99% 71.42%
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative Expense of Revenue of Amarin Corporation PLC

Most recent Selling, General and Administrative Expense of Revenueof AMRN including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative Expense of Revenue of Amarin Corporation PLC

Amarin Corporation PLC Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 92.82% 96.34%
2021 63.85% 72.49% 69.39% 74.42% 70.03%
2020 69.84% 76.78% 68.28% 86.41% 75.45%
2019 67.02% 73.45% 72.83% 97.76% 75.3%
2018 103.05% 90.31% 102.47% 98.83% 99.03%
2017 66.16% 70.09% 69.73% 98.65% 74.29%
2016 80.69% 79.61% 78.72% 109.7% 85.62%
2015 88.31% 124.41% 147.14% 155.28% 123.59%
2014 111.63% 136.19% 167.33% 187.7% 146.39%
2013 220.57% 336.48% 617.47% 1677.36% 469.79%
2012 0.0% 0.0% 0.0% 0.0% 0.0%
2011 0.0% 0.0% 0.0%

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology